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Purpose. To determine the characteristics of MSCs from hip and compare them to MSCs from knee. Methods. Synovial tissues
were obtained from both the knee and the hip joints in 8 patients who underwent both hip and knee arthroscopies on the same
day. MSCs were isolated from the knee and hip synovial samples. The capacities of MSCs were compared between both groups.
Results. The number of cells per unit weight at passage 0 of synovium from the knee was significantly higher than that from the
hip (𝑃 < 0.05). While it was possible to observe the growth of colonies in all the knee synovial fluid samples, it was impossible
to culture cells from any of the hip samples. In adipogenesis experiments, the frequency of Oil Red-O-positive colonies and the
gene expression of adipsin were significantly higher in knee than in hip. In osteogenesis experiments, the expression of COL1A1
and ALPP was significantly less in the knee synovium than in the hip synovium. Conclusions. MSCs obtained from hip joint have
self-renewal and multilineage differentiation potentials. However, in matched donors, adipogenesis and osteogenesis potentials of
MSCs from the knees are superior to those from the hips. Knee synovium may be a better source of MSC for potential use in hip
diseases.
1. Introduction
An acetabular labral tear is one of the most common sources
of hip pain and disability and one of the most frequent indi-
cations for hip arthroscopic surgeries. A concomitant labral
tear with underlying femoroacetabular impingement (FAI)
and/or dysplasia are risk factors for future cartilage damage
and hip osteoarthritis [1].
Several standard procedures, including debridement and
microfracture, have been routinely utilized to address chon-
dral damage of the hip joint [2, 3]. In fact, there are studies
that demonstrate favorable short to medium outcomes fol-
lowingmicrofracture treatment of localized cartilage damage
in patients with FAI [4–6]. Other promising procedures such
as osteochondral transplantation and autologous chondro-
cyte implantation (ACI) have been attempted to preserve
cartilage for FAI patients [7]. However, studies on these
newer procedures report consistently poor outcomes with
high rates of conversion to total hip arthroplasty following
hip arthroscopy for FAI patients with early to moderate
osteoarthritis at the time of surgery [6, 8–10]. Thus, patients
with severe cartilage damage are not good candidates for hip
preservation surgery due to the high risk of failure.
Minimally invasive stem cell therapy may be a desirable
strategy to treat cartilage lesions in the hip. Mesenchy-
mal stem cells (MSCs) are incredibly unique candidates for
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use of cell therapy as they can be isolated from various
tissue reservoirs such as bone marrow, adipose tissue, bone
tissues, and synovial tissues [11, 12]. Previous in vitro studies
demonstrated that MSCs can be isolated from synovial fluid
in the knee joints [13]. Synovial MSCs derived from synovial
tissues are superior to these other sources such as bone
marrow and adipose tissues [14]. In addition, a recent in
vivo study demonstrated that MSCs derived from synovial
tissue have greater cartilage regenerating potential through
comparing histological samples following knee injection in
porcine animalmodels [15]. Sekiya et al. were able to translate
this finding clinically and reported good outcomes following
the use of synovial MSCs during arthroscopy for patients
with cartilaginous knee injuries [16–18].Much of the available
literature is on MSCs derived from knee synovial tissues
with a dearth of knowledge regarding MSCs derived from
hip synovial tissues. Therefore, it is essential to evaluate the
proliferation and differentiation potentials of MSCs derived
from hip joints for future applications using MSCs therapy
in the hip. This source of cells could potentially be beneficial
for the treatment of hip disease such as focal chondral lesions
and early OA.
The purpose of this study was (i) to isolate and define
the characteristics of MSCs from synovial fluid and synovial
tissues of the hip joint and (ii) to clarify whether there are any
differences between synovialMSCs from the knee and the hip
joint in the same donor. We hypothesize that MSCs derived
from synovial fluid and synovial tissues of the hip joint can
be isolated with the same proliferation and differentiation
potential as those from the knee joint.
2. Materials and Methods
2.1. Patient Selection, Tissue Collection, and Isolation of Cells.
Approval for the study was granted through the institutional
review board. 423 hip arthroscopic surgeries were performed
by a single surgeon between 2012 and 2014. Of 423 patients,
8 were eligible for this study as they suffered from both hip
and knee intra-articular pathologies. Synovial samples were
obtained from 2 male and 6 female patients (mean age ±
SD; 47.9 ± 14.0 (range 25–64) years) during knee and hip
arthroscopic surgeries. There were 3 premenopausal females
and 3 postmenopausal females. There was no significant
difference between the durations from onset of symptoms
to date of surgery in these 8 patients. Furthermore, the
preoperative osteoarthritis Kellgren-Lawrence grade on radi-
ological classification between both joints for these patients
was comparable (Table 1).
Arthroscopic surgeries for knee and hip pathologies
in each eligible patient were performed on the same day.
Human synovial fluid and synovium of the knee and the
hip were obtained during arthroscopic surgery under general
anesthesia. To minimize variation in sampling, specimens
were harvested from the locations near the tear of meniscus
in the knee and the torn labrum in the hip (Figure 2(a)). In
Figure 2(a), when we harvested hip synovium, we released
tissue junction between capsular ligament (iliofemoral liga-
ment) and synovium and used a rongeur turning back on
capsule to avoid the contamination of the capsule. Synovial
fluid was obtained from the knee and the hip joints after
injection of saline solution (50mL). Synovium of the knee
was obtained near the peripheral site at 5mm distance from
the injury of meniscus with a rongeur under arthroscopic
observation. Synovium in the hip was also obtained from
the peripheral area at 5mm distance adjacent to the labral
tear by using the same procedure. Arthroscopic findings of
meniscus, labrum, and cartilage at the surgery and surgical
procedure at both joints are shown in Table 1.
Synovial fluid was diluted with phosphate-buffered saline
(PBS), filtered through 70 𝜇mnylon filter (Becton Dickinson,
Franklin Lakes, NJ), and placed in six culture dishes (60 cm2
culture dish; Nalge Nunc International, Rochester, NY).
Both synovial samples were digested in 3mg/mL colla-
genase from Type V (Sigma-Aldrich, St. Louis, Missouri) in
𝛼-modified Eagle’s medium (𝛼-MEM, Invitrogen, Carlsbad,
CA) at 37∘C. After 2 hours, the digested nucleated cells of
synovium were plated at 103, 104, and 105 cells per 60 cm2
culture dish (Nalge Nunc International, Rochester, NY), with
6 dishes created for each cell concentration. Cells were seeded
in complete culture medium containing 𝛼-MEM and 20%
fetal bovine serum (FBS). A high concentration of FBS was
used to induce the highest number of colony-forming units
after cell culture derived from hip synovial fluid among 6 lots
of FBS. The cells were incubated at 37∘C with 5% humidified
CO
2
. After 3 to 4 days, the medium was changed to remove
nonadherent cells. The adherent cells were then cultured for
14 days as passage 0 without refeeding. After 14 days, three
dishes for each concentration were stained with 0.5% crystal
violet. The optimal initial cell density was determined by (1)
the resultant colony size being unaffected by contact inhibi-
tion and (2) amaximum in number of colonies being reached.
We then harvested the cells plated at optimal densities from
the remaining 3 dishes with Trypsin-EDTA (Invitrogen) and
determined the number of cells at passage 0. The passage
0 cells were replated at 50 cells/cm2 in a 150 cm2 dish and
cultured for 21 days.The cultured cells were cryopreserved by
resuspension at a concentration of less than 106 cells/mL in
10% fetal bovine serum. One-milliliter aliquots were slowly
frozen to avoid cell damage and cryopreserved in liquid
nitrogen (passage 1). To expand the cells, we thawed a frozen
vial of the cells, plated the cells in 60 cm2 culture dishes,
and incubated them for 4 days in a recovery plate. These
cells (passage 2) were used for further analyses as previously
described [19].
2.2. Estimation of the Yield Obtained. To investigate prolif-
eration potential of synovial MSCs from the knee and the
hip joints, we estimated the number of live cells at passage
0 gained from whole volume of each tissue and compared it
to the final count of live cells from our cultures.
2.3. Histological Analysis. Synovial tissues obtained from the
knee and the hip joints were fixed in a solution of 4%
paraformaldehyde (PFA) with 0.1mol/L phosphate buffer
(PB) (pH 7.2), dehydrated through a graded series of alcohol,
and embedded in paraffin. 5 𝜇m slice sections were prepared
onmicrotome.These sections were stained with hematoxylin
and eosin.
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2.4. In Vitro Expandability and Cell Viability Assay. To exam-
ine the in vitro expandability of cells from each type of mes-
enchymal tissue, passage-1 cells were replated at 50 cells/cm2
in 150 cm2 culture dishes every 14 days until their growth
potential was exhausted [14]. To determine the viabilities of
cells in each passage, we analyzed quantitative evaluation on
3 donors with use of LIVE/DEAD Viability/Cytotoxicity Kit
for mammalian cells (Invitrogen). In addition, a colorimetric
assay for cell viability was conducted by plating passages 4
and 7 cells at 5000 cells in a 24-well multidish (Nalge Nunc
International).These cells were cultured with 500𝜇L of com-
plete medium for 7 days. After incubation of the cells, 50 𝜇L
of Cell Counting Kit-8 (highly water-soluble tetrazolium salt,
WST-8, Dojindo, Kumamoto, Japan) was added to each well,
and the dish was incubated for 1 hour. Cells were counted
with a spectrophotometermultiplate reader 450 nm (SH1000,
Corona Electric, Ibaraki, Japan). Cell viability was evaluated
and expressed as a percentage based on the viable cell count
of the synovium in knee (100%). At last, we analyzed the
correlation between the fold increase and cell viability on each
of the samples.
2.5. Differentiation Assays
2.5.1. Adipogenesis in a Colony-Forming Assay. One hundred
passage-2 cells were plated in 60 cm2 dishes and cultured in
completemedium for 14 days.Themediumwas then switched
to adipogenic medium 𝛼-MEM supplemented with 10% FBS,
10−7M dexamethasone (Sigma-Aldrich), 0.5mM isobutyl-1-
methylxanthine (Sigma-Aldrich), and 50𝜇M indomethacin
(WAKO, Tokyo, Japan) for an additional 21 days. These
cultured cells were fixed in 4% PFA and stained with fresh
Oil Red-O (Sigma-Aldrich) solution.The number of Oil Red-
O-positive colonies was then counted. The same adipogenic
cultured cells were subsequently stained with crystal violet,
and total cell colonies were counted.
2.5.2. Osteogenesis in a Colony-Forming Assay. One hundred
passage-2 cells were plated in 60 cm2 dishes and cultured for
14 days. The medium was then switched to osteogenic dif-
ferentiation medium consisting of 𝛼con supplemented with
10%FBS, 10−9Mdexamethasone, 20mM𝛽-glycerophosphate
(WAKO), and 50 𝜇g/mL ascorbate-2-phosphate for an addi-
tional 21 days. After 4% PFA fixation and positive colonies
were counted, mineralized bone nodule formation was
assessed by double labeling for mineral (von Kossa stain)
and alkaline phosphate (ALP). The same osteogenic cultures
were subsequently stainedwith crystal violet and the total cell
colonieswere counted. Colonies thatwere<2mm indiameter
and appeared yellow in color were discounted [14].
2.5.3. In Vitro Chondrogenesis Using Pellet Culture Assay.
250,000 passage-3 cells were placed in a 15mL polypropylene
tube (Becton Dickinson) and centrifuged at 450𝑔 for 10min.
The pellets were cultured in chondrogenesis medium (high-
glucose Dulbecco’s modified Eagle’s medium (Invitrogen)
supplemented with 500 ng/mL BMP-2, 10 ng/mL TGF 𝛽3
(R&D Systems; Minneapolis, MN), 10−7M dexamethasone
(Sigma-Aldrich), 50𝜇g/mL ascorbate-2-phosphate, 40 𝜇g/
mL proline, 100 𝜇g/mL pyruvate, and 50mg/mL ITS+Premix
(Becton Dickinson)). For microscopy, the pellets were
embedded in paraffin, cut into 4 𝜇m sections, and stained
with Toluidine Blue [16].
2.5.4. Immunohistochemistry. Four-micrometer-thick sec-
tions obtained from the tissue specimens were deparaf-
finized and incubated with primary anti-human collagen
II antibody (ab34712, Abcam, Cambridge, UK) for 30min
at 4∘C. The sections were rinsed again with PBS repeat-
edly and then incubated with immune-peroxidase polymer
secondary antibody (Histofine, Nichirei Biosciences, Tokyo,
Japan) for 30min. Antibodies were visualized by treating the
sections with diaminobenzidine tetrahydrochloride (Chem-
Mate DAB+ Chromogen, DakoCytomation) for 5min. To
assess the specificity of immunohistochemistry of COLII, the
sections of human chondrosarcomawere stained as described
above as our positive control.
2.5.5. Epitope Profile. One million passage-3 cells were re-
suspended in 200𝜇L of PBS containing a fluorescein iso-
thiocyanate- (FITC-) or phycoerythrin- (PE-) coupled anti-
body. The FITC- or PE-coupled antibodies against CD34,
CD44, CD45, CD90, CD147, and CD271 were from BD
Biosciences (San Diego, CA), CD117 was from eBioscience
(San Diego, CA), and CD105 and CD166 were from Ancell
(Bayport, MN). Vascular endothelial growth factor receptor
2 (VEGFR2) was obtained from R&D Systems (Minneapolis,
MN). Cell fluorescence was evaluated by flow cytometry
using an EPICS XL instrument (Coulter Co., Tokyo, Japan),
and data were analyzed using a MultiCycle AV analysis
program (Phoenix Flow System, Inc., San Diego, CA) [20].
2.6. Quantitative Real-Time RT-PCR. Cells that entered adi-
pogenesis or osteogenesis were trypsinized, and total RNA
was obtained with RNeasy mini plus kit (Qiagen) according
to the manufacturer’s protocol. The chondrogenic pellet
was homogenized using BioMasher (Nippi, Tokyo, Japan),
and total RNA was prepared from a single pellet using
RNeasy micro plus kit (Qiagen, Hilden, Germany). After
total RNA was reverse-transcribed, cDNA was assayed three
times with 10 TaqMan probes for adipogenesis, osteogenesis,
and chondrogenesis. For adipogenesis, adipsin (Complement
FactorD;Hs00157263 m1), peroxisomeproliferator-activated
receptor 𝛾 (PPARG; Hs01115513 m1), and lipoprotein lipase
(LPL; Hs00173425 m1) were used. For osteogenesis, collagen
type I alpha 1 (COL1A1; Hs00164004 m1), alkaline phos-
phatase placental type (ALP; Hs03046558 s1), runt-related
transcription factor 2 (RUNX2; Hs00231692 m1), and bone
gamma-carboxyglutamate protein (BGLAP; Hs01587814 g1)
were used. For chondrogenesis, collagen type II alpha
1 (COL2A1; Hs00264051 m1), collagen type X alpha 1
(COL10A1; Hs00166657 m1), and sex determining region Y-
box 9 (SOX9; Hs00165814 m1) probes (Applied Biosystems)
were used. To detect an adequate endogenous control gene,
we performed gene expression assay with TaqMan Array
Human Endogenous Control (Applied Biosystems) using
s001658 (ACTB; Hs99999903 m1) as a relevant control for




































Figure 1: Data on cell samples obtained from the synovium of each case on 8 donors.
normalization of gene expression (data not shown). StepOne-
Plus Real-Time RT-PCR System was used for the quan-
tification and analysis was performed using StepOnePlus
software (version 2.0, Applied Biosystems).
2.7. Statistical Analysis. To assess the difference in isolation
status and the character of cells from the synovium of knee
and hip, we used Mann–Whitney 𝑈 test. Statistical analyses
were performed using SPSS (version 13, SPSS Inc., Chicago,
IL) software package. The level of significance was set at a
probability value of <0.05.
3. Results
3.1. Macroscopic and Histological Features of Synovium. On
macroscopic analysis, the knee synovium was yellowish and
partially floated in phosphate-buffered saline. On the other
hand, the hip synovium appears to be white and sank to the
bottom as shown in Figures 2(b) and 2(c). Sections from both
synovial samples stained with HE are shown in Figures 2(d)
and 2(e). Synovium fromknee joints consisted of both fibrous
tissues and fatty tissues whereas synovium from hip joints
appeared to have more fibrous tissues than knee joints.
3.2. Cell Isolation from Tissue. Mean sample weight and
nucleated cell number per milligram are shown in Table 2.
The nucleated cell number per milligram of the synovium
from knee was significantly higher than that of the hip (knee:
10.5 ± 8.1 × 103/mg versus hip: 3.1 ± 2.2 × 103/mg, 𝑃 = 0.02).
Data on the nucleated cell number permilligram and number
of colonies of each case is shown on Figure 1. The nucleated
cell number permilligramof the synoviumandCFU from the
females were higher than males (nucleated cell number per
milligram, knee: 12.9 ± 8.0 in female versus 3.2 ± 1.9 in male,
hip: 3.4 ± 2.5 in female versus 2.2 ± 0.1 in male) (CFU knee:
143±160 in female versus 123.0±130 inmale, hip: 79.2±63.8
in female versus 59.0±69.3 in male). However, it was difficult
to assess whether there were significant differences because
only two male patients were included in the study.
In order to gain a maximum number of colonies per
amount of nucleated cells, we examined the effect of plating
density on nucleated cells from each type of mesenchymal
tissue from the 8 donors. From synovium of the knee and
the hip, large single cell-derived colonies occurred when
nucleated cells were plated at 104 cells/60 cm2 dish. The
optimal initial cell density was determined as 104/60 cm2
dish (Figure 2(f)). There was no significant difference in
the number of colony-forming units per 104nucleated cells
between knee and hip (𝑃 = 0.33) (Figure 1 and Table 2). The
cells from both types of synovium seemed to be similar in
fibroblastic cell morphology (Figure 2(g)).
There was no significant difference of CFU-f regarding
gender difference in each of the joints.
3.3. Cell Isolation from Synovial Fluid. Sample volume and
nucleated cell number per milligram of each synovial fluid in
both the knee and the hip joints are shown in Table 3. There
was no significant difference of nucleated cell number per
milligram of the synovial fluid between the knee and the hip
(knee: 5.7 ± 10.5 × 105/mL versus hip: 3.2 ± 7.5 × 105/mL,
𝑃 = 0.20). Colonies were observed in all samples obtained
from the knee synovial fluid but not in all samples from the































Figure 2: (a) Arthroscopic observation and sample harvesting. (b), (c) Macroscopic features of from knee and hip synovium were examined
on a 1mm scare and in PBS. (d), (e) Histological analysis was performed on tissues stained with hematoxylin and eosin (HE). (f)
Representative cell colonies derived from synovium of a donor stained with crystal violet showing large colonies when the nucleated cells
were plated at 104 cells/dish. There was no significant difference in the number of colonies between both MSCs from knee and hip joints. (g)
Representative morphologic features of the cells magnified at 14 days (passage 0) showing fibroblastic spindle cell morphology. Bar = 100𝜇m.
(h) Representative cell colonies stained with crystal violet derived from the synovial fluid of a donor showing large colonies from the knee,
but no colonies from the hip.
Table 2: Data on cell samples obtained from the synovium of 8 donors. Values are shown as mean ± standard deviation. Nucleated cells were
plated at 104/60 cm2.
Source Sample weight (mg) Number of nucleatedcells (×103)/mg Number of colonies
Number of nucleated
cells/colony Yield obtained (×10
6)
Knee 53.2 ± 31.3 10.5 ± 8.1∗ 138.5 ± 144.1 2.3 ± 1.4 15.5 ± 22.2
Hip 85.3 ± 65.3 3.1 ± 2.2 74.2 ± 60.7 3.8 ± 2.8 5.2 ± 4.9
∗
𝑃 < 0.05; Mann–Whitney U test. The number of nucleated cells per sample weight derived from knee was significantly higher than from hip.
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Table 3: Data on the cell samples derived from synovial fluid of 8 donors. Values are shown as mean ± standard deviation.




cells/colony Yield obtained (×10
5)
Knee 1.0 ± 0.0 5.7 ± 10.5 3.3 ± 4.9 6.7 ± 11.7 1.6 ± 3.1
Hip 1.2 ± 0.4 3.2 ± 7.5 0 0 0





















Figure 3: Proliferating potential of both hip and knee cells on 3
donors. Both passage-1 cells were plated at 50 cells/cm2 on 150 cm2
dishes. Thereafter, the cells were replated at 50 cells/cm2 every 14
days until their expansion potential was lost. The expandabilities
were lost at passage 8 in bothMSCs derived fromknee andhip joints.
hip synovial fluid (Table 3 and Figure 2(h)). Thus, analysis
to compare number of colonies between the synovial fluids
of the knee and the hip was not performed. The number of
colony-forming fibroblasts was 3.3 ± 4.9 in the knee joints.
3.4. In Vitro Expandability and Cell Viability Assay. Expand-
ability was lost after eight passages for both types of
synovium-derived cells (Figure 3). Using a LIVE/DEADVia-
bility/Cytotoxicity Kit, both types of passages 1 to 3 cells were
determined to be alive. In passage 4, cells derived from the
knee synovium were thriving but cells derived from the hip
synovium were losing viability (Figure 4(a)). Using a Cell
Counting Kit-8 assay, viability of cells derived from the knee
synovium was significantly higher than that of cells derived
from the hip synovium (knee versus hip, 100% versus 88.4%,
𝑃 < 0.01, Mann–WhitneyU test) (Figure 4(b)). On the other
hand, the half of both cells was dead at passage 7. At passage
7, there was no significant difference of cell viability between
knee and hip with both cell lines nonviable. In addition, there
was a strong correlation between the fold increase and cell
viability (𝑅2 = 0.71) (Figure 4(c)).
3.5. Yield Obtained. The live passage-0 cell number per
colony of synovium from knee and hip was 2.3 ± 1.4 and
3.8 ± 2.8, respectively (×105 cells/mg, 𝑃 = 0.23, Mann–
Whitney 𝑈 test). There was no significant difference in the
yield of live cells obtained from both samples (knee versus
hips, 15.5 ± 22.2 × 106 versus 5.2 ± 4.9 × 106 cells, 𝑃 = 0.16)
(Table 2).
3.6. Adipogenesis. In an adipogenesis differentiation assay,
all samples generated colonies of adipocytes, which stained
with Oil Red-O (Figure 5(a)). However, the rate of Oil Red-
O-positive colonies was significantly higher in cells derived
from the knee as compared to those from the hip (Figure 5(b);
𝑃 < 0.05, Mann–Whitney U test). In addition, real-time
quantitative PCR analysis for adipogenic gene expression
was performed (𝑛 = 3). As shown in Figure 5(c), the gene
expression of adipsin in the knee group was significantly
higher than those in the hip (𝑃 < 0.05, Mann–Whitney 𝑈
test).There were no significant differences in gene expression
of PPARG and LPL between both joints (𝑃 = 0.26 and 0.26,
Mann–Whitney 𝑈 test).
3.7. Osteogenesis. In an osteogenesis differentiation assay,
cells derived from the knee synovium generated colonies
of osteogenic cells that stained with von Kossa/ALP double
staining (Figure 6(a)). Rates of von Kossa- and ALP-positive
colonies in relation to the total number of colonies between
cells derived from the knee and the hip joints were found
to be not statistically different between the knee and the hip
(Figure 6(b)) (𝑃 = 0.20, Mann–Whitney U test). According
to real-time PCR assay, the levels of gene expressions ofCOL1
and ALP in cells from the hip were significantly higher than
those in cells from the knee (3 donors, Figure 6(c); 𝑃 < 0.01
(COL1A1), 𝑃 = 0.04 (ALP)). In contrast, the gene expressions
of RUNX2 and BGLAP genes in cells from the knee were
significantly higher than those in cells from the hip (3 donors,
Figure 6(c); 𝑃 < 0.01 (RUNX2), 𝑃 < 0.01 (BGLAP), Mann–
Whitney 𝑈 test). These findings indicate that osteogenic
potential ofMSCs from the hip joint is equivalent to that from
the knee joint, but osteogenic rate of MSCs from the knee
joint is greater than that from the hip joint [21].
3.8. Chondrogenesis. In chondrogenesis differentiation as-
says, most of the pellets from each tissue were >0.5mm in
diameter. The pellets of both samples had positive Toluidine
Blue stained cartilage matrix. There was no significant dif-
ference of the mean diameter of pellets between both pellets
(knee: 825 𝜇m versus hip: 800 𝜇m, 𝑃 = 0.82, Mann–Whitney
𝑈 test). Immunoreactivity for type II was found in both
pellets (Figure 7(a)) but immunoreactivity for typeX collagen
was not. The real-time PCR study demonstrated that the
gene expression of Col2A1 in pellets derived from the knee












































Figure 4: (a) LIVE/DEADViability/Cytotoxicity Kit assay. At passage 1, green fluorescence was observed in all cells derived from both joints,
confirming that these cells were alive. Passage-4 cells derived from knee were alive, but the part of cells from hip was dead. At passage 7, the
half of both cells was dead. (b) Cell Counting Kit-8 assay for passages 4 and 7 cells on 3 donors.The bar means standard deviation. At passage
4, viability of cells derived from knee was significantly higher than those from hip (𝑃 < 0.01, Mann–Whitney 𝑈 test). At passage 7, there was
no significant difference of cell viability between knee and hip. ∗Significant difference. (c) The correlation between the fold increase and cell
viability on each sample at passages 4 and 7.
was significantly higher than that in pellets derived from the
hip (Figure 7(b); 𝑃 < 0.01, Mann–Whitney 𝑈 test). There
were no significant differences of the expressions of COL10A1
and SOX9 between both pellets (Figure 7(b)). These findings
suggest that the chondrogenic potential of MSCs from the
hips is nearly comparable to that from the knee joint despite
the expression of Col2A1 from the kneeMSCs being superior
to that from the hip MSCs.
3.9. Epitope Profile. The rate of positivity for CD45 (hemato-
poietic cell marker), CD31 (endothelial cell marker), CD117
(C-kit, stem cell factor receptor), CD34 (hematopoietic pro-
genitor cell antigen), CD166 (ALCAM, SB10), VEGFR2 (Flk-
1), and NGFR was <2% in cells derived from both types of
synovium (Figure 8). The mean rate of positivity for CD44
(hyaluronan receptor) from cells of the knee and the hip
was 83.8% and 84.1%, and CD90 (Thy1) [22] was 95.8% and
97.4%. Similarly, positivity for CD105 (SH-2) from cells of
the knee and the hip was 19.3% and 21.0%, respectively, and
CD147 (neuregulin) [23] was 57.7% and 57.1%, respectively
(Figure 8). These findings showed that surface markers of
each of the cells were similarly expressed [19].
4. Discussion
This study has four major findings. First, we determined that
adherent cells derived from the synovium of the hip joints
can be isolated with consistent proliferation andmultilineage
differentiation potentials. Second, we found that colony-
forming units, fibroblasticmorphology, and epitope profile of
MSCs derived from synoviumof the hip joints were similar to
MSCs derived from synovium of the knee joints. Third, there
was a difference in the number of nucleated cells derived from
synovium per milligram, colony-forming units derived from
synovial fluid, proliferation rate, adipogenesis, osteogenesis,
and the expression of COL2A1 during chondrogenesis in
MSCs synovium from the knee joints compared to the hip





































Figure 5: Adipogenic potential about each synovial cell. (a) Colonies staining positively with Oil Red-O and crystal violet in each cell. (b)
Proportion of Oil Red-O-positive colonies in relation to the total number of colonies in eachMSC. Values are shown as themean and standard
deviation of 6 donors. ∗The rate of Oil Red-O-positive colonies from the knee was significantly higher than that from hip (Mann–Whitney
U test, 𝑃 < 0.0001). (c) Quantitative real-time PCR data from 3 representative donors are shown. The bar means standard deviation.
joints. Fourth, the yield obtained from synovium of the knee
joints was slightly higher but not more significant than the
hip joints.
One of the strengths of this study is that we compared the
proliferation and differentiation potentials between synovial
MSCs of two joints from the same donor. Previous studies
demonstrated that the condition of the donors could poten-
tially affect the ability ofMSCs to function and suggested that
MSCs differ in property and vary from donors to donors [24–
26]. By providing same donor samples, we are avoiding this
potential bias. Siegel et al. demonstrated that age and gender
affect the growth potential of MSCs derived from human
bone marrow [26]. Lee et al. demonstrated that estradiol
affected MSCs’ potential and proliferation rate in a porcine
animal model [27]. They concluded that MSCs of females
were affected by menopause. Matsukura et al. demonstrated
that a longer period of time between onset of pain and surgery
in patients with meniscus injury increased the amount of
MSCs derived from human synovial fluid [24]. Sekiya et al.
also demonstrated thatMSCs derived from human synovium
in patients with severe osteoarthritis have greater potential
of proliferation compared to healthy patients [25]. However,
they did not find any significant difference when comparing
onset of pain to surgery or severity of osteoarthritis (OA).
In this study, we isolated adherent cells derived from
synoviumof the hip and the knee joints. Our findings demon-
strated that these synovial cells from both the knee and the
hip joints have proliferation and multilineage differentiation
potentials. MSCs from both joints had a morphologically
spindle shape, similar to that of fibroblasts, with functional
capacities to proliferate and differentiate into multilineage
cells. In addition, cells from both joints expressed similarly
surface markers. Sakaguchi et al. and Segawa et al. demon-
strated that cells derived from human synovium and bone
marrow were negative for CD34 and CD45 and positive for
CD90, CD105, and CD44 [14, 20]. Similarly, our findings
reveal that expressions of both cells were negative for CD34,
CD45, CD31, CD117, NGFR, and VEGFR2 and positive for
CD44, CD90, CD105, andCD147.These findings indicate that
both knee and hip synovial derived MSCs expressed similar
cell surface epitopes to those fromother cell sources including
bone marrow and adipose tissues. International Society for





















































Figure 6: Osteogenic potential of each type of MSCs. (a) Colonies stained positively with von Kossa and ALP as well as crystal violet. (b)
Proportion of von Kossa and ALP-positive colonies in relation to the total number of colonies. Values are the mean and standard deviation
of 6 donors. ∗There was no significant difference in the rate of von Kossa and ALP-positive colonies between knee and hip (Mann–Whitney
U test, 𝑃 = 0.20). (c) Real-time RT-PCR. Gene expressions of COL1 and ALP in knee were significantly lower than those in hip (Mann–
Whitney 𝑈 test, 𝑃 < 0.05); on the other hand gene expressions of RUNX2 and BGLAP in the knee were significantly higher than in the hip
(Mann–Whitney 𝑈 test, 𝑃 < 0.05). The bar means standard deviation.
Cellular Therapy position statement defined that MSCs are
as follows: (1) adherent cells to plastic, (2) specific surface
marker expression, and (3)multipotent differentiation poten-
tial. In this study, we were able to define MSCs from both the
hip and the knee joints according to the criteria stated above.
In this study, we investigated the yield obtained and
expandability as part of the proliferation potential of MSCs
derived from synovial fluid and synovial tissue in both the
knee and the hip joints. Our data demonstrated that there
were no significant differences in colony numbers per 104
nucleated cells, number of nucleated cells per colony between
the hip and the knee joints. In addition, the expandability of
MSCs from both the knee and the hip was lost at the same
time point (passage 8). However, the number of nucleated
cells per milligram derived from synovium in the knee was
significantly higher than that derived from that in the hip
joint. Yield obtained derived from synovium in the knee
joints was also not significantly, but still higher than in the
hip joints. MSCs derived from synovial fluid of the hip were
not capable of proliferating at passage 0. Indeed, LIVE/DEAD
Viability experiments determined that both types of passage
1 cells were alive. At passage 4, cells derived from knee
synovium were still alive. In contrast, reduction of viability
was evident in those MSCs derived from the hip joint. These
findings suggest that the potential of proliferation derived
from synovial MSCs in the knee joints was superior to those
in the hip joint.
Previously, it has been suggested that the potential of
synovial MSCs can be affected by the presence of cartilage
injury and the period between the onset of pain and date of
surgery [28]. However, in this study, there was no significant
difference in growth potential despite varied time frame
between onset of pain and date of surgery for both the knee
and the hip joints for our patients.
We also investigated the multilineage differentiation
capability of MSCs derived from synovium in the hip and the
knee. Our findings revealed that adipogenic differentiation
potential in the knee jointwas significantly higher than that in
































Figure 7: Chondrogenic potential of each type of synovial cell. (a) The pellets from each sample were shown. There was no significant
difference in the diameter of pellets between knee and hip (𝑃 = 0.82, Mann–Whitney 𝑈 test). Histological analysis was performed on tissues
stained with Toluidine Blue staining and immunocytochemical analysis with type II collagen by tissue source and human chondrosarcoma
for positive control. (b) Real-time RT-PCR.The bar means standard deviation. Expression ofCOL2 gene in knee was significantly higher than
that in hip (𝑃 < 0.05, Mann–Whitney U test). ∗Significant difference.
the hip joints. Interestingly, our histological findings revealed
that synovial tissues from the knee joints appear to have
slightly more fatty tissues than from the hip joints. These
findings may be associated with why the hip synovial MSCs
have lower adipogenic differentiation potential than the knee
synovial MSCs. In fact, Mochizuki et al. described that the
fibrous knee synovium, which is distinct from adipose syn-
ovium (infra patella fat pad), has comparable chondrogenic
potential with adipose synovium and fibrous synovium has
lower adipogenic potential than adipose synovium in the
knee joint [29]. Our histological finding of the knee synovial
tissue appears to be similar to theirs of adipose synovium.
Our findings also revealed that osteogenic differentiation
potential in the knee joints was higher than that in the hip
joints. The rate of von Kossa- and ALP-positive colony was
not significantly different between both joints; however the
expressions of RUNX2 and BGLAP in synovialMSCs derived
from the knee joints at real-time PCR were significantly
higher than the hip joints. On the other hand, the expressions
of ALP in synovial MSCs derived from the knee joints at real-
time PCR were significantly lower than the hip joints. ALP is
an early marker of osteogenesis. Contrarily, RUNX2 is a late
marker of osteogenesis [21, 30]. Thus, our findings suggest
that synovialMSCs derived from the knee differentiatedmore
rapidly than those from the hip. This study determined that
the potential of osteogenic differentiation of synovial MSCs
from the knee was higher and faster than that from the hip.
Previous studies addressed the potential of the knee
synovial MSCs for expansion and multiple mesenchymal
lineage differentiation [11, 12]. De Bari et al. first described
that synovium membrane derived cells had extensive expan-
sion potential in monolayer culture [11]. Sakaguchi et al.
demonstrated that synovium from the knee was superior
as a potential source of MSCs among five tissues (bone
marrow, synovium, periosteum, skeletal muscle, and adipose
tissue). They noted that knee synovial MSCs had the greatest
expansion and differentiation ability among these tissues
[12]. In addition, our previous study revealed that the shoul-
der synovial MSCs derived from subacromial bursa which
were retained at passage 10 had the greatest differentiation
potential compared to other tissues such as bone marrow,
entheses, and bone [19]. In keeping with these studies, we
compared potential of MSCs derived from synovial tissues
in the knee and the hip joints within the same donor. Our
findings indicated that synovial MSCs from the knee joints
have superior capability of giving rise to adipogenic and













20 40 60 80 1000
Figure 8: Flow cytometry analysis of the expression of cell surface
markers related to stem cells, hematopoietic stem cells, and endothe-
lial cells in each population of cells derived from each sample.
Passage-2 cells from 3 donors were examined, and similar results
were obtained. Positive expression rates are shown.
osteogenic tissues compared to those from the hip joints. In
addition, our results suggest that synovial MSCs from the
knee have a higher yield compared to the hip.
In this study, we demonstrated that synovial MSCs from
the knee have greater potential and differentiation capacity
to those in the hip in the same donors. We showed that the
nucleated cell number per milligram of sample from the knee
synovium was significantly higher than that from the hip
synovium. The reason why MSCs in the hip have a lower
potential of MSCs than that in the knee remains unclear.
Study Limitations. There are some limitations in this study.
First, our study population was small. The prevalence of
simultaneous hip and knee arthroscopy is very low in the
normal practice. Thus, it is extremely difficult to get the
opportunity to collect synovial tissues from both joints on the
same day. There is the risk of sample bias with proliferation
assay due to the small sample size. Second, since this is an
in vitro study, we are unable to demonstrate the potential
of these MSCs in vivo. Third, we did not compare synovial
MSCs toMSCs from other sources including bonemarrow or
adipose tissues. Fourth, histological characteristic of the knee
synovium was different from the hip synovial tissue in this
study. In order to eliminate the possibility of contamination
of fat pad tissue or joint capsule, we obtained the tissue
sample consistently by harvesting the synovium near the torn
meniscus or acetabular torn labrum. Fifth, in real-time PCR
study, there is possibility that interdonor variability could be
larger than the difference between the knee and the hip joint.
In conclusion, our findings suggest that isolated MSCs
from the hip synovial cells have self-renewal andmultilineage
differentiation potentials. However, adipogenesis and osteo-
genesis potentials of MSCs from the knees are superior to
those ofMSCs from the hips in the samedonor.MSCs derived
from the knee synovial tissuemay be a better source for future
mesenchymal stem cell therapy.
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